Group 1 - The core viewpoint of the article highlights the significance of dexterous hands as high-performance end effectors that mimic human hand structure and function, enabling precise control and complex movements for various applications in commercial, industrial, and daily life settings [1] - The company strategically invested 20.41% equity in Shanghai Aoyi Information Technology Co., Ltd. in November 2025, indicating a commitment to advancing technology in the robotics sector [1] - Aoyi Technology, established in 2015, is one of the few companies in China that integrates both "brain-computer interface" and "robotics" technologies, with a product range that includes intelligent bionic hands, EEG systems, wearable exoskeletons, and robotic dexterous hands [1] Group 2 - In the field of robotic dexterous hands, Aoyi Technology has established strong partnerships with several robotic main engine customers, showcasing its collaborative approach and market presence [1]

Group 1 - The core viewpoint of the article highlights that Aoyi Technology, established in 2015, is one of the few companies in China that simultaneously masters both "brain-computer interface" and "robotics" technologies [1] - Aoyi Technology focuses on several business sectors including neuro-rehabilitation medical devices, smart assistive devices, health consumer electronics, and core components and control systems for robotics [1] - The company produces and sells products such as smart bionic hands, smart EEG systems, wearable exoskeletons, and robotic dexterous hands [1] Group 2 - Aoyi Technology's smart bionic hand is noted as the first in China and the third globally to receive FDA and CE certification, with sales covering multiple countries and regions including the USA, Middle East, Russia, Ukraine, and India [1] - The dexterous hand has become a leading product in the domestic humanoid robot sector, with over 200 partner companies collaborating with Aoyi Technology [1]

Core Viewpoint - The company, Aoyi Technology, established in 2015, is one of the few in China that simultaneously masters both "brain-computer interface" and "robotics" technologies, focusing on various sectors including neuro-rehabilitation medical devices, smart assistive devices, health consumer electronics, and robotic components and control systems [1] Group 1: Company Overview - Aoyi Technology specializes in producing and selling products such as smart bionic hands, intelligent EEG systems, wearable exoskeleton devices, and robotic dexterous hands [1] - The smart bionic hand developed by Aoyi Technology is the first high-end prosthetic limb in China and the third globally to receive FDA and CE certification, with sales covering multiple countries and regions including the USA, Middle East, Russia, Ukraine, and India [1] Group 2: Market Position - Aoyi Technology's dexterous hand has become a leading product in the domestic humanoid robot sector, with over 200 partner companies collaborating with them [1]

Company Overview - 雷迪克 was established in 2002, focusing on automotive bearing components, with clients including major manufacturers like Geely and SAIC [3] - The company went public on the Shenzhen Stock Exchange in 2017 and has multiple production bases [3] - Recent investments include acquiring 20.41% of Aoyi Technology and establishing a joint venture for robotics development [3] Aoyi Technology Business - Aoyi Technology, founded in 2015, specializes in neural interfaces and robotics, producing products like intelligent prosthetic hands and wearable exoskeletons [3][4] - The intelligent prosthetic hand is the first in China and third globally to receive FDA and CE certifications, with sales in various countries [3][4] Brain-Computer Interface (BCI) Industry - The BCI industry is transitioning from research to commercialization, with significant policy support from the "14th Five-Year Plan" [4] - Current BCI applications are primarily in clinical trials, with limited scalable implementations [4] - Challenges include signal accuracy, real-time decoding, and interdisciplinary integration [4][5] Aoyi's Core Technologies - Aoyi focuses on non-invasive BCI technologies, developing high-precision EEG and EMG systems [6] - Applications include: - Intelligent prosthetic hand systems for upper limb amputees [6] - Rehabilitation systems for patients with upper limb disabilities [6] - Integrated research and diagnostic platforms for EEG and EMG [6] Future Outlook for BCI - The BCI industry is expected to first impact the medical field, particularly in treating neurological disorders, before expanding into industrial and consumer electronics [7] - Aoyi plans to develop tools for clinical neuroscience and address various neurological conditions, including stroke and anxiety disorders [7] Collaboration Between 雷迪克 and Aoyi - 雷迪克 invested 160 million CNY in Aoyi's B3 financing round and co-founded Zhejiang Lei Ao Robotics [7] - The partnership aims to integrate precision transmission components with Aoyi's robotics technology, enhancing production capabilities [7] International Expansion - 雷迪克 plans to invest 30 million USD in a new automotive bearing production facility in Tangier, Morocco, to improve delivery times to European, African, and Middle Eastern clients [8] - The project has completed overseas direct investment registration, with preparations underway [8]